Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Millennials and Baby Boomers – What their Stock Portfolio Reveals

Although millennials are now of age, their influence on the stock market is still in its infancy. The question is, can they produce better results than the older generation, known as baby boomers, who are soon to retire? To get the answer to this question, two stock portf...
Carl Cotton | August 26, 2019 |

Will Powell Decouple Gold from the Stock Market?

This week, Powell gave a long television interview and a testimony to the Senate. What groundbreaking did he say, and what do his remarks imply for the gold market? Powell Gives Interview and Testifies Powell dominated media news this week. On Sunday, the Fed Chair gave...
Arkadiusz Sieron | May 21, 2020 |

XPhyto: Outperforming Leading Cannabis Stocks

I recently wrote about an increasingly popular but still mostly overlooked medical cannabis company that is innovating industry-leading transdermal and oral thin film drug delivery systems. ( https://stockhouse.com/opinion/independent-reports/2020/01/08/the-golden-bullet-for-d...
Marc Davis | January 29, 2020 |

XPhyto: Why Rapid PCR Testing is Here to Stay

Regular coronavirus testing is destined to become the norm for many years to come, regardless of how many people get vaccinated against COVID-19. So says Hugh Rogers, the CEO of XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) ( OTC: XPHYF ) , a Canadian life scie...
Marc Davis | April 22, 2021 |

Why A Multi-Billion-Dollar Diamond Discovery Looms Large

The discovery of Canada’s next multi-billion-dollar diamond deposit is long overdue. Truth be told, a truly big, world-class diamond discovery has not been made in Canada since the 90s. However, there has been a renewed push in recent years to unlock the ge...
Marc Davis | February 25, 2019 |

XPhyto: The Cutting Edge of Medical Cannabis Science

At the forefront of the next wave of cannabis commercialization, is a German-focused company with headquarters in Vancouver, XPhyto Therapeutics Corp. (CSE: XPHY; FSE: 4XT) , that is building a much-coveted cannabis R&D cultivation facility in a converted nuclear bunker and o...
Marc Davis | November 12, 2019 |

The Golden Bullet for Drug Delivery

It’s the Holy Grail in the cannabis industry. Everyone is trying to innovate the best delivery system to optimize the “bioavailability” (uptake) of medical cannabis in order to offer the perfect pairing -- precise dosing with a fast on...
Marc Davis | January 8, 2020 |

How Kodiak Copper Bedazzles via the Drill-Bit

It’s shaping up to be one of the most prolifically­-sized, high-grade copper discoveries in North America in recent memory. Kodiak Copper Corp’s ( TSX.V: KDK , OTC: KDKCF ) latest round of drill results at its MPD copper-gold project in sou...
Marc Davis | November 10, 2020 |

XPhyto Announces a PCR Testing Breakthrough

It’s the technological breakthrough that the world has been waiting for. A small Canadian life sciences company, XPhyto Therapeutics Corp. ( CSE:XPHY ) (FSE:4XT), has just announced its ability to significantly speed up testing for COVID-19 in an...
Marc Davis | December 17, 2020 |

XPhyto Therapeutics: Are they Selling the Solution to Germany’s Rapid Testing Crisis?

The Germans call it COVID-19 “rapid testing mania”. But like most manias, it has opened up a Pandora’s box of problems. As the speed of the vaccine rollout program falters in Europe, on-the-spot antigen testing continues to be the ...
Marc Davis | June 2, 2021 |
1 2 3 4 5 6 7 8 9 10 ...